Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels

NCT05691231 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.

NCT NCT05691231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05691231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels
Lead sponsor
NuVasive
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 18, 2023
Completion date
May 10, 2029
Enrollment
158 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical disc disease, degenerative disc disease